By Colin Kellaher

 

Sanofi SA on Wednesday said it plans to invest more than 600 million euros (US$703 million) to build a new manufacturing plant in Canada aimed at increasing production of its Fluzone flu vaccine.

The Paris pharmaceutical giant said the new plant, which it will build at its existing site in Toronto, will provide more antigen and filling capacity for the high-dose influenza vaccine.

Sanofi said the plant, which it expects to be operational in 2026, will help increase availability of Fluzone in Canada, the U.S. and Europe. The company currently produces the vaccine exclusively at its plant in Swiftwater, Pa.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

March 31, 2021 10:35 ET (14:35 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Sanofi Charts.
Sanofi (EU:SAN)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Sanofi Charts.